-
First Immunotherapy Approved for Breast CancerMedical oncologist Leisha A. Emens discusses the significance of the first U.S. Food and Drug Administration approval of an immunotherapy treatment for breast cancer.
by Anna Azvolinsky
-
Treating Cancer Based on Its Genetics, Not Its LocationMedical oncologist and sarcoma specialist George D. Demetri explains the significance of the recent approval of the oral drug Vitrakvi based on tumor genetics.
by Anna Azvolinsky
-
An Uncommon PartnershipThrough the Angiosarcoma Project, researchers are partnering with patients to learn about a rare cancer.
by Ashley P. Taylor
-
The Genetics of Metastatic CancerThe multiple tumors in patients with metastatic disease share key genetic traits, a sequencing study shows.
by Anna Azvolinsky
-
Paying for Tumor TestingA recent U.S. government decision about coverage of tumor sequencing could affect cancer patients.
by Brad Jones
-
The Ins and Outs of Tumor TestingIn a session at the AACR Annual Meeting, oncologists discussed the state of cancer precision medicine—and engaged with patient advocates.
by Kate Yandell
-
A New Type of Drug ApprovalAt the AACR Annual Meeting, researchers and regulators discuss what it means to tie approval of an immunotherapy to tumors' molecular characteristics, not to their tissues of origin.
by Kate Yandell
-
A Better Way to Screen for Lynch Syndrome?Researchers say a next-generation sequencing test could improve screening in colorectal cancer patients for a hereditary syndrome that raises cancer risk. Some experts have concerns.
by Cheryl Platzman Weinstock
People with cancer face an increased risk of financial hardship. Education and expert guidance can offer patients a lifeline.
by Thomas Celona
Taking Answers HomeAdvocates bring the patient perspective to the AACR Annual Meeting 2024 and leave with tools to better communicate advances in care to others.
by Eric Fitzsimmons
Lifestyle Choices and CancerWhat people eat and drink and their level of physical activity can affect their risk of having cancer. New interventions aim to reduce risk factors.
by Kevin McLaughlin
Improving Colorectal Cancer Screening OptionsTests currently in development seek to offer greater accuracy and reach more people.
by Eric Fitzsimmons
-
Chemtai Mungo, MD, MPH: Bringing Cervical Cancer Treatment to More WomenAn innovative self-treatment strategy for cervical precancer could save lives in low- and middle-income countries as well as underserved areas in the U.S.
-
From the Bench: Creative Approaches in Cancer ResearchInsects that smell cancer, new CRISPR delivery tools, and a cancer-fighting battery—the AACR's new blog series, From the Bench, highlights creative approaches in cancer research.
